Nobazit (Enisamium iodide) 20 pills 250 mg

Nobazit (Enisamium iodide) 20 pills 250 mg

SKU:2065
To favorites
Nobazit (Enisamium iodide) direct-acting antiviral agent for the treatment of influenza and SARS in adults and adolescents from 12 years of age, effectively suppresses the action of influenza viruses and SARS
Active substance:Enisamium iodide
Pharmacological group:Antiviral
Formulation:Tablets
Dosage mg:250
In stock
$22
11
Description
Features
Reviews

Instructions for Nobazit (Enisamium iodide) 20 pills 250 mg

English product name
nobazite

Release form
tab, film coating, 125 mg: 10 or 20 pcs
tab, film coating, 250 mg: 10 or 20 pcs

Description Nobazit:

Tablets covered with a film shell of yellow color, round, double-convex; Cross-section: light yellow to yellow or yellow with a greenish tint.

1 tab.
enisamia iodide (100% anhydrous) 125 mg
Auxiliary substances:
(core) lactose monohydrate (breast sugar) - 33.4 mg,
cellulose microcrystalline (vivapur 101) - 10 mg,
sucrose (refined sugar) - 9 mg,
povidone (polyvinylpyrrolidone low-molecular medical or plasdon K-17) - 3.6 mg,
copovidone (plasdon S-630) - 1.4 mg,
crospovidone (polyplasdon XL-10) - 3.8 mg,
talc - 1.9 mg,
calcium stearate - 1.9 mg.

Shell Composition:
Aquarius Prime BAN314047 Yellow - 6 mg (hypromellose - 3.96 mg,
titanium dioxide - 1.3437 mg,
capril/caprilate (caprile/caprine triglyceride) - 0.54 mg,
iron oxide yellow dye - 0.042 mg,
iron oxide red dye - 0.0003 mg,
quinoline yellow dye - 0.114 mg).

10 pcs - packages of contour compartments (1) - cardboard packs.
10 pcs - packages of contour compartments (2) - cardboard packages.

ATC codes
J05AX Other antiviral drugs

Clinical-pharmacological groups / Group affiliation
An antiviral and immunomodulating preparation. Interferon synthesis inductor

Active substance
enisamia iodide

Pharmacotherapy group Nobazit
Antiviral agent

Testimony Nobazit:

  • Treatment of influenza and other ARVIs,
  • including complex therapy.

Method of use, course and dosage Nobazit:

Inside. Individual dosing regime, depending on indications and clinical situation.

Use in renal dysfunction
It is not recommended for use in severe renal dysfunction.

Use in case of impaired liver function
It is not recommended for use in severe violations of liver function.

Use in elderly patients
There are no specific restriction guidelines for use.

Use in children
Contraindicated in children and adolescents under the age of 18 years.

  • Nosology (ICD codes)
  • J06.9
  • Acute upper respiratory tract infection unspecified
  • J10
  • Influenza caused by an identified seasonal influenza virus

Pharmacological effect Nobazit:

An antiviral agent derived from isonicotinic acid. It effectively suppresses the action of influenza viruses and other causative agents of acute respiratory viral infections (SARS) due to direct (inhibiting) effect on the process of virus penetration through the cell membrane.

Features
Active substance
Pharmacological group
Formulation
Dosage mg
Pills in 1 package
Country of origin
Brand
Expiration Date
No reviews yet — your comment may be first.
All reviews 0
general rating
Analogues